| regulation of lipid catabolic process | GO:0050994 | 15 | 1.000 | Fly |
| negative regulation of lipid catabolic process | GO:0050995 | 6 | 0.998 | Fly |
| triglyceride catabolic process | GO:0019433 | 9 | 0.952 | Fly |
| lipid catabolic process | GO:0016042 | 69 | 0.933 | |
| sequestering of triglyceride | GO:0030730 | 6 | 0.903 | Fly |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.898 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.894 | Fly |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.840 | Fly |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.829 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.797 | Fly |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.758 | Fly |
| negative regulation of execution phase of apoptosis | GO:1900118 | 4 | 0.752 | |
| regulation of sequestering of triglyceride | GO:0010889 | 6 | 0.731 | |
| fat cell differentiation | GO:0045444 | 160 | 0.707 | |
| regulation of lipid storage | GO:0010883 | 20 | 0.697 | Fly |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.691 | |
| positive regulation of sequestering of triglyceride | GO:0010890 | 4 | 0.663 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.650 | Fly |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.611 | |
| acylglycerol catabolic process | GO:0046464 | 11 | 0.552 | Fly |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.538 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.531 | |
| regulation of fatty acid oxidation | GO:0046320 | 10 | 0.528 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.525 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.523 | |
| intestinal absorption | GO:0050892 | 13 | 0.486 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.456 | |
| apoptotic dna fragmentation | GO:0006309 | 7 | 0.443 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.439 | |
| lipid storage | GO:0019915 | 36 | 0.435 | Fly |
| fatty acid catabolic process | GO:0009062 | 25 | 0.428 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.422 | |
| positive regulation of protein deacetylation | GO:0090312 | 9 | 0.422 | |
| cellular response to peptide | GO:1901653 | 92 | 0.419 | |
| gluconeogenesis | GO:0006094 | 39 | 0.409 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.395 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.384 | |
| actin cytoskeleton reorganization | GO:0031532 | 21 | 0.382 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.358 | Fly |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.355 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.348 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.339 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.330 | |
| dna metabolic process | GO:0006259 | 303 | 0.330 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.324 | |
| response to testosterone | GO:0033574 | 3 | 0.321 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.320 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.320 | Fly |
| camera type eye development | GO:0043010 | 266 | 0.317 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.308 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.296 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.290 | |
| sterol metabolic process | GO:0016125 | 58 | 0.286 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.286 | |
| chromatin organization | GO:0006325 | 206 | 0.284 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.283 | Fly |
| response to organonitrogen compound | GO:0010243 | 246 | 0.278 | |
| hexose metabolic process | GO:0019318 | 98 | 0.278 | |
| multicellular organism growth | GO:0035264 | 161 | 0.268 | |
| diacylglycerol metabolic process | GO:0046339 | 6 | 0.266 | |
| positive regulation of triglyceride catabolic process | GO:0010898 | 3 | 0.266 | Fly |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.263 | |
| defense response to other organism | GO:0098542 | 197 | 0.261 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.255 | |
| protein deacetylation | GO:0006476 | 32 | 0.254 | |
| single organism nuclear import | GO:1902593 | 95 | 0.253 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.252 | |
| lipid oxidation | GO:0034440 | 29 | 0.251 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.248 | |
| chromatin modification | GO:0016568 | 187 | 0.246 | |
| head morphogenesis | GO:0060323 | 34 | 0.240 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.235 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.234 | |
| hair follicle development | GO:0001942 | 85 | 0.231 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.224 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.220 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.218 | |
| nitrogen cycle metabolic process | GO:0071941 | 3 | 0.217 | |
| regulation of planar cell polarity pathway involved in outflow tract morphogenesis | GO:2000163 | 1 | 0.216 | |
| regulation of histone deacetylation | GO:0031063 | 12 | 0.212 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.208 | |
| keratinocyte migration | GO:0051546 | 3 | 0.205 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.203 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.202 | |
| epidermis development | GO:0008544 | 187 | 0.200 | |
| microtubule based process | GO:0007017 | 236 | 0.199 | Fly |
| positive regulation of histone deacetylation | GO:0031065 | 7 | 0.198 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.197 | |
| response to peptide hormone | GO:0043434 | 127 | 0.196 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.196 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.195 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.192 | |
| protein deacylation | GO:0035601 | 36 | 0.190 | |
| cell division | GO:0051301 | 120 | 0.189 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.184 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.183 | Fly |
| sterol transport | GO:0015918 | 38 | 0.182 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.180 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.180 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.180 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.178 | |
| positive regulation of gluconeogenesis | GO:0045722 | 11 | 0.178 | |
| cholesterol storage | GO:0010878 | 4 | 0.174 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.170 | Fly |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.168 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.163 | |
| protein localization to organelle | GO:0033365 | 185 | 0.162 | Fly |
| positive regulation of histone modification | GO:0031058 | 28 | 0.161 | |
| regulation of apoptotic dna fragmentation | GO:1902510 | 5 | 0.159 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.159 | |
| intestinal cholesterol absorption | GO:0030299 | 5 | 0.155 | |
| glucose homeostasis | GO:0042593 | 128 | 0.154 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.150 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.147 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.146 | |
| toxin transport | GO:1901998 | 38 | 0.145 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.144 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.143 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.143 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.143 | |
| negative regulation of cellular response to insulin stimulus | GO:1900077 | 16 | 0.140 | |
| regulation of cell activation | GO:0050865 | 289 | 0.139 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.138 | |
| regionalization | GO:0003002 | 337 | 0.138 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 8 | 0.136 | |
| amine metabolic process | GO:0009308 | 45 | 0.135 | |
| mitochondrion organization | GO:0007005 | 134 | 0.134 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.134 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.133 | |
| cholesterol transport | GO:0030301 | 38 | 0.132 | |
| endomembrane system organization | GO:0010256 | 147 | 0.131 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.130 | |
| negative regulation of peptide hormone secretion | GO:0090278 | 16 | 0.130 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.129 | |
| cellular response to increased oxygen levels | GO:0036295 | 1 | 0.129 | |
| nuclear import | GO:0051170 | 95 | 0.128 | |
| negative regulation of lipid storage | GO:0010888 | 6 | 0.127 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.125 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.125 | |
| stem cell differentiation | GO:0048863 | 268 | 0.124 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.124 | |
| response to growth factor | GO:0070848 | 198 | 0.124 | |
| urea metabolic process | GO:0019627 | 3 | 0.123 | |
| negative regulation of muscle hypertrophy | GO:0014741 | 9 | 0.121 | |
| regulation of response to food | GO:0032095 | 10 | 0.120 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.119 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.119 | |
| negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | GO:2000164 | 1 | 0.118 | |
| negative regulation of tyrosine phosphorylation of stat5 protein | GO:0042524 | 2 | 0.117 | |
| adaptive immune response | GO:0002250 | 155 | 0.117 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.116 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.114 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.114 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.112 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.112 | |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.109 | Fly |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.108 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.108 | |
| fatty acid beta oxidation | GO:0006635 | 16 | 0.107 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.105 | |
| mapk cascade | GO:0000165 | 281 | 0.103 | |
| locomotory behavior | GO:0007626 | 195 | 0.098 | |
| nuclear transport | GO:0051169 | 139 | 0.097 | |
| nuclear envelope organization | GO:0006998 | 11 | 0.096 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.095 | |
| cell maturation | GO:0048469 | 127 | 0.095 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.094 | |
| response to insulin | GO:0032868 | 100 | 0.093 | |
| hormone secretion | GO:0046879 | 128 | 0.092 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.092 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.092 | |
| response to food | GO:0032094 | 17 | 0.091 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.090 | |
| apoptotic process involved in development | GO:1902742 | 28 | 0.090 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.090 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.089 | |
| developmental maturation | GO:0021700 | 193 | 0.089 | |
| cellular response to prostaglandin stimulus | GO:0071379 | 2 | 0.089 | |
| urogenital system development | GO:0001655 | 261 | 0.088 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.087 | |
| activation induced cell death of t cells | GO:0006924 | 10 | 0.086 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.086 | |
| cation transport | GO:0006812 | 399 | 0.086 | |
| membrane organization | GO:0061024 | 245 | 0.086 | |
| regulation of histone modification | GO:0031056 | 56 | 0.086 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.086 | |
| insulin secretion | GO:0030073 | 89 | 0.084 | |
| white fat cell differentiation | GO:0050872 | 15 | 0.084 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.084 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.083 | |
| collagen biosynthetic process | GO:0032964 | 7 | 0.083 | |
| heart morphogenesis | GO:0003007 | 178 | 0.083 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.082 | |
| glutamate metabolic process | GO:0006536 | 9 | 0.081 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.079 | |
| stem cell development | GO:0048864 | 219 | 0.078 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.078 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.078 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.078 | |
| skin development | GO:0043588 | 220 | 0.077 | |
| lipid modification | GO:0030258 | 65 | 0.077 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.077 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.075 | |
| ossification | GO:0001503 | 216 | 0.074 | |
| fatty acid oxidation | GO:0019395 | 28 | 0.073 | |
| germ cell development | GO:0007281 | 185 | 0.073 | |
| organelle fission | GO:0048285 | 170 | 0.072 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.072 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.072 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.072 | |
| inflammatory response | GO:0006954 | 244 | 0.071 | |
| histone deacetylation | GO:0016575 | 26 | 0.071 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.070 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.070 | |
| peptide transport | GO:0015833 | 133 | 0.070 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.069 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.068 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.068 | |
| hair cycle | GO:0042633 | 90 | 0.067 | |
| regulation of execution phase of apoptosis | GO:1900117 | 9 | 0.067 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.067 | |
| response to stilbenoid | GO:0035634 | 22 | 0.067 | |
| protein ubiquitination | GO:0016567 | 171 | 0.067 | |
| negative regulation of hormone secretion | GO:0046888 | 20 | 0.066 | |
| odontogenesis | GO:0042476 | 78 | 0.066 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.065 | |
| regulation of sterol transport | GO:0032371 | 17 | 0.065 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.065 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.065 | |
| endoplasmic reticulum organization | GO:0007029 | 10 | 0.065 | |
| regulation of appetite | GO:0032098 | 12 | 0.065 | |
| protein targeting | GO:0006605 | 143 | 0.064 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.064 | |
| negative regulation of reactive oxygen species biosynthetic process | GO:1903427 | 0 | 0.064 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.064 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.063 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.063 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.063 | |
| lateral line system development | GO:0048925 | 1 | 0.062 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.062 | |
| apoptotic nuclear changes | GO:0030262 | 9 | 0.062 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.062 | |
| regulation of defense response | GO:0031347 | 233 | 0.062 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.060 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.060 | |
| lipid localization | GO:0010876 | 126 | 0.060 | Fly |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.059 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.059 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.059 | |
| face morphogenesis | GO:0060325 | 29 | 0.059 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.058 | |
| lipid transport | GO:0006869 | 98 | 0.058 | Fly |
| central nervous system neuron development | GO:0021954 | 67 | 0.058 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.057 | |
| metanephros development | GO:0001656 | 79 | 0.057 | |
| regulation of muscle hypertrophy | GO:0014743 | 13 | 0.057 | |
| dephosphorylation | GO:0016311 | 129 | 0.056 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.056 | |
| cellular homeostasis | GO:0019725 | 240 | 0.056 | |
| caveola assembly | GO:0070836 | 2 | 0.056 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.055 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.054 | |
| notochord cell development | GO:0060035 | 1 | 0.054 | |
| cellular protein complex disassembly | GO:0043624 | 36 | 0.054 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.054 | |
| adult behavior | GO:0030534 | 135 | 0.053 | |
| positive regulation of metalloenzyme activity | GO:0048554 | 3 | 0.053 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.053 | |
| cellular component disassembly involved in execution phase of apoptosis | GO:0006921 | 9 | 0.053 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.052 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.052 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.052 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.052 | |
| cellular response to starvation | GO:0009267 | 57 | 0.052 | |
| muscle tissue development | GO:0060537 | 308 | 0.051 | |
| ear development | GO:0043583 | 200 | 0.051 | |
| lipoprotein transport | GO:0042953 | 7 | 0.051 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.051 | |
| t cell activation | GO:0042110 | 289 | 0.051 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.051 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.051 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.051 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.050 | |
| cation homeostasis | GO:0055080 | 212 | 0.050 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.050 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.050 | |
| negative regulation of t cell proliferation | GO:0042130 | 38 | 0.049 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.049 | |
| regulation of glutamine family amino acid metabolic process | GO:0000820 | 1 | 0.049 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.048 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.047 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.047 | |
| positive regulation of phagocytosis engulfment | GO:0060100 | 3 | 0.047 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.047 | |
| immune effector process | GO:0002252 | 321 | 0.046 | |
| molting cycle | GO:0042303 | 90 | 0.046 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.046 | |
| protein complex disassembly | GO:0043241 | 40 | 0.046 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.046 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.045 | |
| muscle atrophy | GO:0014889 | 3 | 0.045 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.045 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.045 | Fly |
| histone modification | GO:0016570 | 159 | 0.045 | |
| wnt signaling pathway involved in somitogenesis | GO:0090244 | 4 | 0.045 | |
| regulation of p38mapk cascade | GO:1900744 | 3 | 0.044 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.044 | |
| response to peptide | GO:1901652 | 136 | 0.044 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.044 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.043 | |
| protein depolymerization | GO:0051261 | 34 | 0.043 | |
| membrane biogenesis | GO:0044091 | 12 | 0.043 | |
| acylglycerol homeostasis | GO:0055090 | 16 | 0.043 | |
| myeloid dendritic cell activation | GO:0001773 | 25 | 0.042 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.042 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.042 | |
| negative regulation of platelet derived growth factor receptor beta signaling pathway | GO:2000587 | 2 | 0.042 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.042 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.042 | |
| response to low density lipoprotein particle | GO:0055098 | 2 | 0.042 | |
| cerebellum development | GO:0021549 | 77 | 0.042 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.041 | |
| response to vitamin a | GO:0033189 | 1 | 0.041 | |
| palate development | GO:0060021 | 76 | 0.041 | |
| stat protein import into nucleus | GO:0007262 | 6 | 0.041 | |
| cellular response to vitamin | GO:0071295 | 2 | 0.041 | |
| muscle fiber development | GO:0048747 | 76 | 0.041 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.041 | |
| action potential | GO:0001508 | 78 | 0.040 | |
| synaptic transmission | GO:0007268 | 329 | 0.040 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.040 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.040 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.039 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.039 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.039 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.039 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.038 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 19 | 0.038 | |
| chromosome segregation | GO:0007059 | 48 | 0.038 | |
| digestion | GO:0007586 | 40 | 0.038 | |
| oogenesis | GO:0048477 | 56 | 0.038 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.038 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.038 | |
| placenta development | GO:0001890 | 140 | 0.038 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.038 | |
| coagulation | GO:0050817 | 78 | 0.038 | |
| negative regulation of sequestering of triglyceride | GO:0010891 | 2 | 0.038 | |
| positive regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process | GO:2000060 | 8 | 0.037 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.037 | |
| face development | GO:0060324 | 38 | 0.037 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.037 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.037 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.037 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.037 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.037 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.037 | |
| dna catabolic process | GO:0006308 | 19 | 0.037 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.036 | |
| nuclear division | GO:0000280 | 158 | 0.036 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.035 | |
| striated muscle atrophy | GO:0014891 | 2 | 0.035 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.035 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.035 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.035 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.035 | |
| intracellular protein transport | GO:0006886 | 204 | 0.035 | |
| kidney development | GO:0001822 | 213 | 0.034 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.034 | |
| protein import | GO:0017038 | 101 | 0.034 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.034 | |
| extracellular structure organization | GO:0043062 | 148 | 0.034 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.034 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 4 | 0.034 | |
| glycosylation | GO:0070085 | 62 | 0.034 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.034 | |
| cellular response to hyperoxia | GO:0071455 | 1 | 0.033 | |
| glucose metabolic process | GO:0006006 | 92 | 0.033 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.033 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.033 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.033 | |
| mitotic sister chromatid segregation | GO:0000070 | 14 | 0.033 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.032 | |
| temperature homeostasis | GO:0001659 | 26 | 0.032 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.032 | |
| execution phase of apoptosis | GO:0097194 | 19 | 0.032 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.032 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.032 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.031 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.031 | |
| tissue remodeling | GO:0048771 | 102 | 0.031 | |
| circadian rhythm | GO:0007623 | 114 | 0.031 | |
| collagen metabolic process | GO:0032963 | 17 | 0.031 | |
| amide transport | GO:0042886 | 138 | 0.031 | |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.031 | |
| bone morphogenesis | GO:0060349 | 78 | 0.031 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.031 | |
| intracellular cholesterol transport | GO:0032367 | 3 | 0.030 | |
| ammonia assimilation cycle | GO:0019676 | 2 | 0.030 | |
| regulation of cholesterol transport | GO:0032374 | 17 | 0.030 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.030 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.030 | |
| negative regulation of striated muscle tissue development | GO:0045843 | 18 | 0.030 | |
| cognition | GO:0050890 | 149 | 0.030 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.030 | |
| neuronal action potential | GO:0019228 | 54 | 0.030 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.030 | |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.029 | |
| bone remodeling | GO:0046849 | 53 | 0.029 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.029 | |
| negative regulation of platelet derived growth factor receptor signaling pathway | GO:0010642 | 7 | 0.029 | |
| regulation of cell migration | GO:0030334 | 219 | 0.029 | |
| jak stat cascade | GO:0007259 | 42 | 0.029 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.029 | |
| negative regulation of oxidoreductase activity | GO:0051354 | 4 | 0.029 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.029 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.029 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.029 | |
| plasma membrane repair | GO:0001778 | 7 | 0.028 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.028 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.028 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.028 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.028 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.028 | |
| sodium ion transport | GO:0006814 | 73 | 0.028 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.028 | |
| regulation of platelet derived growth factor receptor signaling pathway | GO:0010640 | 9 | 0.028 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.028 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.028 | |
| connective tissue development | GO:0061448 | 179 | 0.028 | |
| p38mapk cascade | GO:0038066 | 4 | 0.028 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.028 | |
| regulation of system process | GO:0044057 | 200 | 0.028 | |
| t cell proliferation | GO:0042098 | 120 | 0.028 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.028 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.028 | |
| wound healing | GO:0042060 | 157 | 0.028 | |
| bile acid metabolic process | GO:0008206 | 17 | 0.028 | |
| limb morphogenesis | GO:0035108 | 149 | 0.028 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.027 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.027 | |
| cellular response to oxygen levels | GO:0071453 | 20 | 0.027 | |
| organelle localization | GO:0051640 | 179 | 0.027 | Fly |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.027 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.027 | |
| regulation of phagocytosis engulfment | GO:0060099 | 5 | 0.027 | |
| regulation of non canonical wnt signaling pathway | GO:2000050 | 12 | 0.027 | |
| regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061178 | 31 | 0.027 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.026 | |
| regulation of protein binding | GO:0043393 | 60 | 0.026 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.026 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.026 | |
| regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:2000150 | 1 | 0.026 | |
| membrane assembly | GO:0071709 | 12 | 0.026 | |
| response to estrogen | GO:0043627 | 24 | 0.026 | |
| gland development | GO:0048732 | 330 | 0.026 | |
| neuropeptide signaling pathway | GO:0007218 | 19 | 0.026 | |
| phenol containing compound biosynthetic process | GO:0046189 | 21 | 0.026 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.026 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.025 | |
| positive regulation of cholesterol transport | GO:0032376 | 9 | 0.025 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.025 | |
| regulation of ion transport | GO:0043269 | 215 | 0.025 | |
| cell fate commitment | GO:0045165 | 210 | 0.025 | |
| negative regulation of muscle tissue development | GO:1901862 | 20 | 0.025 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.025 | |
| adipose tissue development | GO:0060612 | 25 | 0.025 | |
| response to nutrient levels | GO:0031667 | 109 | 0.025 | |
| regulation of the force of heart contraction by chemical signal | GO:0003057 | 5 | 0.025 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.025 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.025 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.025 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.025 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.025 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.024 | |
| muscle system process | GO:0003012 | 141 | 0.024 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.024 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.024 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.024 | |
| mesonephros development | GO:0001823 | 97 | 0.024 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.024 | |
| tolerance induction to self antigen | GO:0002513 | 4 | 0.024 | |
| maintenance of location | GO:0051235 | 89 | 0.024 | Fly |
| mitotic cell cycle process | GO:1903047 | 159 | 0.024 | |
| regulation of multicellular organismal metabolic process | GO:0044246 | 14 | 0.024 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.024 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.024 | |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.024 | |
| positive regulation of tissue remodeling | GO:0034105 | 19 | 0.023 | |
| negative regulation of peptide secretion | GO:0002792 | 16 | 0.023 | |
| spermatogenesis | GO:0007283 | 284 | 0.023 | |
| ovulation cycle | GO:0042698 | 59 | 0.023 | |
| renal system development | GO:0072001 | 225 | 0.023 | |
| defense response to virus | GO:0051607 | 68 | 0.023 | |
